ALPHA TRIBE

Samsrita Labs LtdBoard Meeting, 25-10-2025: Board Meeting

25-10-2025 | 05:22 pm

Samsrita Labs board approved Q2/H1 financial results, reporting a loss of ₹4.94 Cr. The company purchased a cancer drug patent for ₹2.36 Cr and acquired a 28.62% stake in QROPS Advisory Services via share swap, now an associate.

No comments yet. Be the first to comment!

All announcements from Samsrita Labs Ltd